Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
WuXi Biologics (Cayman) Inc
OTC:WXIBF
WuXi Biologics (Cayman) Inc
OTC:WXIBF
Price:
6.21
USD
Market Closed
Market Cap:
$27B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
WXIBF Price Forecast
Based on 24 analysts
Based on 24 analysts
+26% Upside
from
$6.21
today
WuXi Biologics (Cayman) Inc (WXIBF)’s 12-month stock price forecast through November 2027 has a consensus target of $7.83, implying 26% upside. The forecast is based on price targets from 24 Wall Street analysts.
WXIBF Analyst Rating
No ratings yet
No ratings yet
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WXIBF's stock price target?
Price Target
7.83
USD
7.83
USD
According to Wall Street analysts, the average 1-year price target for WXIBF is 7.83 USD with a low forecast of 4.61 USD and a high forecast of 10.4 USD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
22%
22%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
